Trigli LS 1mg/500mg/15mg Tablet SR
Marketer
Ordain Health Care Global Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Trigli LS 1mg/500mg/15mg Tablet SR
Metformin/glimepiride/pioglitazone extended-release tablets (1mg/500mg/15mg) are a triple-combination medication designed to manage elevated blood glucose. This medication, used in conjunction with a healthy diet and regular exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Dosage and treatment duration for Metformin/glimepiride/pioglitazone extended-release tablets should strictly adhere to your physician's instructions. Administer this medication with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume the regular schedule. Never double the dose. An overdose can result in dangerously low blood sugar (hypoglycemia). Concurrent use with other antidiabetic medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is essential. Other potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating women should seek medical counsel before using this medication. Kidney function tests will be assessed before treatment begins. Limit alcohol consumption, as this can elevate the risk of adverse effects.
Uses of Trigli LS 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Trigli LS 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trigli LS 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer this extended-release tablet with a meal.
Common Side effects of Trigli LS 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Trigli LS 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trigli LS 1mg/500mg/15mg Tablet SR whole; do not fracture, pulverize, or chew it. Administer this extended-release tablet with a meal.
How Trigli LS 1mg/500mg/15mg Tablet SR works:
Trigli LS 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone to manage blood sugar levels. This triple-drug approach offers superior glycemic control when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Trigli LS 1mg/500mg/15mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Trigli LS 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Trigli LS 1mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with either hypoglycemia or hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Trigli LS 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Trigli LS 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Trigli LS 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is necessary. Trigli LS 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Trigli LS 1mg/500mg/15mg Tablet SR :
Should you forget to take a Trigli LS 1mg/500mg/15mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trigli LS 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
3,018 People bought this recently